Transient ischemic attack (TIA) carries a substantial short-term risk for stroke, which is a leading cause of disability and death in the United States. Despite the existing evidence-based guidelines for secondary prevention of stroke, variability in the assessment, diagnostic testing, and treatment
Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials
✍ Scribed by Guido Grassi; Francesca Arenare; Fosca Quarti Trevano; Raffaella Dell’Oro; Giuseppe Mancia
- Book ID
- 107541501
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 155 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1522-6417
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Recent cases of fraud in clinical trials have attracted considerable media attention, but relatively little reaction from the biostatistical community. In this paper we argue that biostatisticians should be involved in preventing fraud (as well as unintentional errors), detecting it, and quantifying
Abstract One hundred and thirty-seven consecutive acute superficial abscesses were randomly allocated to incision, curettage and primary suture without parenteral antibiotics (64 cases) or to conventional treatment with incision, drainage and dressings (73 cases). Wound healing was faster; 7.0 days: